INCY vs IQV
Incyte Corporation and Iqvia Holdings Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | INCY | IQV |
|---|---|---|
| Revenue | $5.1B | $16.3B |
| Net income | $1.3B | $1.4B |
| Gross margin | 92.8% | 52.4% |
| Net margin | 25.0% | 8.3% |
| Return on equity | 29.9% | 21.6% |
| Diluted EPS | $6.41 | $7.84 |
| Dividend / share | — | — |
| Payout ratio | — | 319.8% |
| Free cash flow | $892.1M | $2.1B |
| Equity | $5.2B | $6.5B |
| Net debt / equity | 9.31× | 2.11× |
| Current ratio | 3.32× | 0.75× |
| Revenue CAGR 5y | 14.0% | 7.5% |
| Profit CAGR 5y | — | 37.3% |
IQV bills 3.2× the revenue of INCY, and INCY keeps more of each dollar of revenue as profit (25.0% against 8.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | INCY | IQV |
|---|---|---|
| FY2025 | $5.1B | $16.3B |
| FY2024 | $4.2B | $15.4B |
| FY2023 | $3.7B | $15.0B |
| FY2022 | $3.4B | $14.4B |
| FY2021 | $3.0B | $13.9B |
| FY2020 | $2.7B | $11.4B |
| FY2019 | $2.2B | $11.1B |
| FY2018 | $1.9B | $10.4B |
| FY2017 | $1.5B | $9.7B |
| FY2016 | $1.1B | $6.8B |
Net income by year
Bottom line
| Fiscal year | INCY | IQV |
|---|---|---|
| FY2025 | $1.3B | $1.4B |
| FY2024 | $32.6M | $1.4B |
| FY2023 | $597.6M | $1.4B |
| FY2022 | $340.7M | $1.1B |
| FY2021 | $948.6M | $966.0M |
| FY2020 | $-295.7M | $279.0M |
| FY2019 | $446.9M | $191.0M |
| FY2018 | $109.5M | $259.0M |
| FY2017 | $-313.1M | $1.3B |
| FY2016 | $104.2M | $72.0M |
Advertisement
AdSense · Rectangle 336×280